Share this @internewscast.com
While it remains uncertain whether mental health treatments like antidepressants or psychotherapy could mitigate cardiovascular risk, established treatments such as statins and blood pressure-lowering drugs are effective in reducing the risk of serious cardiac events once cardiovascular risk factors are present.
Contrary to the traditional assumption that young women have a low risk of heart disease, a new study underscores the need to reconsider this notion, especially concerning those grappling with anxiety or depression. The research, to be presented at the American College of Cardiology’s Annual Scientific Session, suggests that mental health conditions could expedite the onset of cardiovascular risk factors among young and middle-aged women.
Rising Rates Of Cardiovascular Risk Factors
Against the backdrop of increasing rates of cardiovascular risk factors and a surge in heart attacks among younger individuals, the study emphasizes the necessity for enhanced cardiovascular screening and preventive care, particularly for women dealing with anxiety or depression. Notably, the prevalence of anxiety and depression has surged in recent years, exacerbated by the COVID-19 pandemic.
Findings From The Study
Analyzing health records of over 71,000 participants, the study revealed that women under 50 with anxiety or depression were nearly twice as likely to develop high blood pressure, high cholesterol, or diabetes over 10 years compared to women without these mental health conditions. This elevated risk placed them nearly on par with men of the same age in terms of heart disease risk.
Implications For Screening And Prevention
The study suggests the importance of implementing cardiovascular risk factor screening among young women with anxiety or depression to mitigate the incidence of cardiovascular disease. Even though young women typically exhibit lower rates of cardiovascular risk factors due to the protective effects of estrogen, anxiety, and depression substantially heighten their relative risk, warranting proactive screening and intervention strategies.
Exploring Neurobiological Pathways
To understand the underlying mechanisms driving this association, researchers examined the metabolic activity of stress-related brain regions in participants who had undergone brain scans. They observed significant increases in stress-related neural activity among younger women with anxiety or depression, indicating potential neurobiological pathways linking mental health conditions to cardiovascular risk.
Treatment Considerations
While it remains uncertain whether mental health treatments like antidepressants or psychotherapy could mitigate cardiovascular risk, established treatments such as statins and blood pressure-lowering drugs are effective in reducing the risk of serious cardiac events once cardiovascular risk factors are present. Further research is needed to elucidate the precise mechanisms linking anxiety and depression to cardiovascular risk and explore potential therapeutic interventions.